Identification of protective antigens by RNA interference for control of the lone star tick, Amblyomma americanum

Vaccine

Volumn 28, Issue 7, 2010, Pages 1786-1795

  de la Fuente, José ^a,b   Manzano Roman, Raúl ^a   Naranjo, Victoria ^a,b   Kocan, Katherine M ^a   Zivkovic, Zorica ^c   Blouin, Edmour F ^a   Canales, Mario ^b   Almazán, Consuelo ^d   Galindo, Ruth C ^b   Step, Douglas L ^a   Villar, Margarita ^b  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^c Department of Infectious Diseases and Immunology   (Netherlands)

^d UNIVERSIDAD AUTÓNOMA DE TAMAULIPAS   (Mexico)

Author keywords

Amblyomma americanum; Lone star tick; RNA interference; Tick; Vaccine

Indexed keywords

PROTEIN 2B7; PROTEIN 2D10; PROTEIN 2G7; PROTEIN C29; RECOMBINANT PROTEIN; SUBOLESIN; UNCLASSIFIED DRUG;

AMBLYOMMA; ANIMAL EXPERIMENT; ARTICLE; CATTLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG EFFICACY; FEMALE; GENE EXPRESSION; INFESTATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA INTERFERENCE; VACCINATION;

ANIMALS; ANTIBODY FORMATION; ANTIGENS; CATTLE; FEMALE; GENE EXPRESSION PROFILING; GENE LIBRARY; IXODIDAE; MALE; POLYMORPHISM, GENETIC; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA INTERFERENCE; SEQUENCE ANALYSIS, DNA; THREONINE-TRNA LIGASE; TICK INFESTATIONS; VACCINES;

EID: 75249093707     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.007     Document Type: Article

References (53)

1. de la Fuente J., Estrada-Peña A., Venzal J.M., Kocan K.M., and Sonenshine D.E. Overview: ticks as vectors of pathogens that cause disease in humans and animals. Front Biosci 13 (2008) 6938-6946
2. Mather T.N., and Mather M.E. Intrinsic competence of three ixodid ticks (Acari) as vectors of the Lyme disease spirochete. J Med Entomol 27 (1990) 646-650
3. Ginsberg H.S., Ewing C.P., O'Connell Jr. A.F., Bosler E.M., Daly J.G., and Sayre M.W. Increased population densities of Amblyomma americanum (Acari: Ixodidae) on Long Island, New York. J Parasitol 77 (1991) 493-495
4. Mount G.A., Haile D.G., Barnard D.R., and Daniels E. New version of LSTSIM for computer simulation of Amblyomma americanum (Acari: Ixodidae) population dynamics. J Med Entomol 30 (1993) 843-857
5. Means R.G., and White D.J. New distribution records of Amblyomma americanum (L.) (Acari: Ixodidae) in New York State. J Vector Ecol 22 (1997) 133-145
6. Kierans J.E., and Lancombe E.H. First records of Amblyomma americanum, Ixodes (Ixodes) dentatus, and Ixodes (Ceratixodes) uriae (Acari: Ixodidae) from Maine. J Parasitol 84 (1998) 629-631
7. Felz J.W., Chandler Jr. F.W., Oliver J.H., Rahn D.W., and Schriefer M.E. Solitary erythema migrans in Georgia and South Carolina. Arch Dermatol 135 (1999) 1317-1326
8. Childs J.E., and Paddock C.D. The ascendancy of Amblyomma americanum as a vector of pathogens affecting humans in the United States. Ann Rev Entomol 48 (2003) 307-337
9. Yabsley M.J., Wimberly M.C., Stallknecht D.E., Little S.E., and Davidson W.R. Spatial analysis of the distribution of Ehrlichia chaffeensis, causative agent of human monocytotropic ehrlichiosis, across a multi-state region. Am J Trop Med Hyg 72 (2005) 840-850
10. Patrick C.D., and Hair J.A. Seasonal abundance of lone star ticks on white-tailed deer. Environ Entomol 6 (1977) 263-269
11. Koch H.G. Suitability of white-tailed deer, cattle and goats as hosts for the lone star ticks. Amblyomma americanum (Acari: Ixodidae). J Can Entomol Soc 61 (1988) 251-257
12. Goddard J., and Varela-Stokes A.S. Role of the lone star tick, Amblyomma americanum (L.), in human and animal diseases. Vet Parasitol 160 (2009) 1-12
13. Graf J.F., Gogolewski R., Leach-Bing N., Sabatini G.A., Molento M.B., Bordin E.L., et al. Tick control: an industry point of view. Parasitology 129 (2004) S427-S442
14. Carroll J.F., Benante J.P., Klun J.A., White C.E., Debboun M., Pound J.M., et al. Twelve-hour duration testing of cream formulations of three repellents against Amblyomma americanum. Med Vet Entomol 22 (2008) 144-151
15. de la Fuente J., and Kocan K.M. Strategies for development of vaccines for control of ixodid tick species. Parasite Immunol 28 (2006) 275-283
16. Sonenshine D.E., Kocan K.M., and de la Fuente J. Tick control: further thoughts on a research agenda. Trends Parasitol 22 (2006) 550-551
17. Willadsen P. Tick control: thoughts on a research agenda. Vet Parasitol 138 (2006) 161-168
18. de la Fuente J., Almazán C., Canales M., Pérez de la Lastra J.M., Kocan K.M., and Willadsen P. A ten-year review of commercial vaccine performance for control of tick infestations on cattle. Anim Health Res Rev 8 (2007) 23-28
19. de la Fuente J., and Kocan K.M. Advances in the identification and characterization of protective antigens for development of recombinant vaccines against tick infestations. Expert Rev Vac 2 (2003) 583-593
20. Almazán C., Kocan K.M., Bergman D.K., Garcia-Garcia J.C., Blouin E.F., and de la Fuente J. Identification of protective antigens for the control of Ixodes scapularis infestations using cDNA expression library immunization. Vaccine 21 (2003) 1492-1501
21. de la Fuente J., Almazán C., Blouin E.F., Naranjo V., and Kocan K.M. RNA interference screening in ticks for identification of protective antigens. Parasitol Res 96 (2005) 137-141
22. de la Fuente J., Kocan K.M., Almazán C., and Blouin E.F. RNA interference for the study and genetic manipulation of ticks. Trends Parasitol 23 (2007) 427-433
23. de la Fuente J., Almazán C., Blas-Machado U., Naranjo V., Mangold A.J., Blouin E.F., et al. The tick protective antigen, 4D8, is a conserved protein involved in modulation of tick blood ingestion and reproduction. Vaccine 24 (2006) 4082-4095
24. Schefe J.H., Lehmann K.E., Buschmann I.R., Unger T., and Funke-Kaiser H. Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. J Mol Med 84 (2006) 901-910
25. de la Fuente J., Maritz-Olivier C., Naranjo V., Ayoubi P., Nijhof A.M., Almazán C., et al. Evidence of the role of tick subolesin in gene expression. BMC Genomics 9 (2008) 372
26. Canales M., Enriquez A., Ramos E., Cabrera D., Dandie H., Soto A., et al. Large-scale production in Pichia pastoris of the recombinant vaccine Gavac™ against cattle ticks. Vaccine 15 (1997) 414-422
27. de la Fuente J., Rodríguez M., Montero C., Redondo M., García-García J.C., Méndez L., et al. Vaccination against ticks (Boophilus spp.): the experience with the Bm86-based vaccine Gavac™. Genet Anal Biomol Eng 15 (1999) 143-148
28. Almazán C., Blas-Machado U., Kocan K.M., Yoshioka J.H., Blouin E.F., Mangold A.J., et al. Characterization of three Ixodes scapularis cDNAs protective against tick infestations. Vaccine 23 (2005) 4403-4416
29. Almazán C., Kocan K.M., Blouin E.F., and de la Fuente J. Vaccination with recombinant tick antigens for the control of Ixodes scapularis adult infestations. Vaccine 23 (2005) 5294-5298
30. Canales M., Almazán C., Naranjo V., Jongejan F., and de la Fuente J. Vaccination with recombinant Boophilus annulatus Bm86 ortholog protein, Ba86, protects cattle against B. annulatus and B. microplus infestations. BMC Biotechnol 9 (2009) 29
31. Canales M., Naranjo V., Almazán C., Molina R., Tsuruta S.A., Szabó M.P.J., et al. Conservation and immunogenicity of the mosquito ortholog of the tick protective antigen, subolesin. Parasitol Res 105 (2009) 97-111
32. de la Fuente J., Blouin E.F., Manzano-Roman R., Naranjo V., Almazán C., Perez de la Lastra J.M., et al. Functional genomic studies of tick cells in response to infection with the cattle pathogen, Anaplasma marginale. Genomics 90 (2007) 712-722
33. Nijhof A.M., Taoufik A., de la Fuente J., Kocan K.M., de Vries E., and Jongejan F. Gene silencing of the tick protective antigens, Bm86, Bm91 and subolesin, in the one-host tick Boophilus microplus by RNA interference. Int J Parasitol 37 (2007) 653-662
34. Kocan K.M., Manzano-Roman R., and de la Fuente J. Transovarial silencing of the subolesin gene in three-host ixodid tick species after injection of replete females with subolesin dsRNA. Parasitol Res 100 (2007) 1411-1415
35. Galindo R.C., Doncel-Pérez E., Zivkovic Z., Naranjo V., Gortazar C., Mangold A.J., et al. Tick subolesin is an ortholog of the akirins described in insects and vertebrates. Dev Comp Immunol 33 (2009) 612-617
36. de la Fuente J., Almazán C., Naranjo V., Blouin E.F., and Kocan K.M. Synergistic effect of silencing the expression of tick protective antigens 4D8 and Rs86 in Rhipicephalus sanguineus by RNA interference. Parasitol Res 99 (2006) 108-113
37. Willadsen P., Smith D., Cobon G., and McKenna R.V. Comparative vaccination of cattle against Boophilus microplus with recombinant antigen Bm86 alone or in combination with recombinant Bm91. Parasite Immunol 18 (1996) 241-246
38. Almazán C., Kocan K.M., Bergman D.K., Garcia-Garcia J.C., Blouin E.F., and de la Fuente J. Characterization of genes transcribed in an Ixodes scapularis cell line that were identified by expression library immunization and analysis of expressed sequence tags. Gene Ther Mol Biol 7 (2003) 43-59
39. Gong H., Liao M., Zhou J., Hatta T., Huang P., Zhang G., et al. Gene silencing of ribosomal protein P0 is lethal to the tick Haemaphysalis longicornis. Vet Parasitol 151 (2008) 268-278
40. Schalla W.O., and Johnson W. Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes. Infect Immun 11 (1975) 1195-1202
41. Swendsen C.L., and Johnson W. Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction. Infect Immun 14 (1976) 345-354
42. Tewari R.P., Lynn M., Birnbaum A.J., and Solotorovsky M. Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae. Infect Immun 19 (1978) 58-65
43. Elad D., and Segal E. Immunogenicity in calves of a crude ribosomal fraction of Trichophyton verrucosum: a field trial. Vaccine 13 (1995) 83-87
44. Melby P.C., Ogden G.B., Flores H.A., Zhao W., Geldmacher C., Biediger N.M., et al. Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library. Infect Immun 68 (2000) 5595-5602
45. Cassataro J., Velikovsky C.A., Giambartolomei G.H., Estein S., Bruno L., Cloeckaert A., et al. Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA. Vaccine 20 (2002) 1660-1669
46. Rajeshwari K., Patel K., Nambeesan S., Mehta M., Sehgal A., Chakraborty T., et al. The P domain of the P0 protein of Plasmodium falciparum protects against challenge with malaria parasites. Infect Immun 72 (2004) 5515-5521
47. Iborra S., Carrion J., Anderson C., Alonso C., Sacks D., and Soto M. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice. Infect Immun 73 (2005) 5842-5852
48. Luo D., Ni B., Li P., Shi W., Zhang S., Han Y., et al. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice. Infect Immun 74 (2006) 2734-2741
49. Gao J., Luo J., Li Y., Fan R., Zhao H., Guan G., et al. Cloning and characterization of a ribosomal protein L23a from Haemaphysalis qinghaiensis eggs by immuno screening of a cDNA expression library. Exp Appl Acarol 41 (2007) 289-303
50. Fumagalli S., Di Cara A., Neb-Gulati A., Natt F., Schwemberger S., Hall J., et al. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol 11 (2009) 501-508
51. Guo D., Hu K., Lei Y., Wang Y., Ma T., and He D. Identification and characterization of a novel cytoplasm protein ICF45 that is involved in cell cycle regulation. J Biol Chem 279 (2004) 53498-53505
52. Jackman J.E., and Phizicky E.M. tRNAHis guanylyltransferase catalyzes a 3′-5′ polymerization reaction that is distinct from G-1 addition. Proc Natl Acad Sci U S A 103 (2006) 8640-8645
53. Trimnell A.R., Davies G.M., Lissina O., Hails R.S., and Nuttall P.A. A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine. Vaccine 23 (2005) 4329-4341